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Abstract
Purpose: Traditional digital subtraction angiography is still regarded as the gold standard in the diagnostics of trans-
plant renal artery stenosis (TRAS). However, this procedure requires a high volume of iodine contrast medium for 
optimal visualisation of the renal artery. The aim of this study was to analyse both the usefulness and the safety of 
intra-arterial computed tomography angiography (IA-CTA) with ultra-low-volume iodine contrast administration 
in the diagnostic and therapeutic management of TRAS in patients with impaired renal transplant function.
Material and methods: Thirty-three patients with a suspicion of TRAS based on Doppler-ultrasound and clinical setting 
underwent IA-CTA with ultra-low iodine contrast volume. A special, author-elaborated CTA protocol was used.  
The volume of 8-18 ml of diluted iodine contrast medium was administered through a catheter with the tip placed 
2 cm below the aortic bifurcation.
Results: In six patients the CTA examinations revealed TRAS in three configurations: in the anastomosis, in the trunk 
(critical and high-grade), or in both sections. Stenoses were treated with primary stenting obtaining favourable ana-
tomical outcome. No intervention-related complications were observed. No contrast-induced acute kidney injury 
was diagnosed in this study. Mean serum creatinine concentration was 2.93 ± 0.89 mg/dl at the baseline and 2.89 ± 
1.73 mg/dl and 2.17 ± 0.51 mg/dl after three and seven days from IA-CTA, respectively.
Conclusions: Intra-arterial CTA with ultra-low volume of iodine contrast seems to be a safe and reliable diagnostic 
tool to detect and assess TRAS in the aspect of stent implantation. Application of this imaging modality eliminates 
the need for a high volume of iodine contrast and thus does not adversely influence renal transplant function.
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Introduction
Transplant renal artery stenosis (TRAS) is a potentially 
reversible complication of kidney transplantation that 
occurs in 1-23% of graft recipients [1]. Symptoms include 
arterial hypertension, vascular murmur over the graft, 
and renal function impairment. Ultrasound with Dop-
pler imaging that reveals high systolic peak velocity of 
blood flow in the transplant renal artery (TRA) remains 
the screening diagnostic measure for TRAS. Traditional 
angiography is used in both the diagnostics and therapy 
for this disorder. During angiography balloon angioplasty 
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with or without stent implantation may be performed. 
The angiography requires a high volume of iodine con-
trast to be administered into the TRA in order to visu-
alise the vessel, asses the stenosis, and eventually to im-
plant the stent. There is a risk of progression of chronic 
allograft injury in the graft recipients with impaired graft 
function through contrast-induced acute kidney injury 
(CI-AKI) or contrast-induced nephropathy (CIN). CI-AKI 
is diagnosed when the serum creatinine level increases by 
0.5 mg/dl or 25% (in relation to the initial level) within 
three days from contrast administration [2]. CT angiogra-
phy with intra-arterial ultra-low volume of iodine contrast 
administration (IA-CTA) is a relatively new method used 
in the diagnosis of TRAS and in the search for the best 
potential stent location in patients with advanced TRAS. 
IA-CTA enables excellent TRA visualisation with ultra-
low volume of contrast applied locally during minimally 
invasive procedure.
The aim of this study was to evaluate the potential use-
fulness and transplant safety of intra-arterial CT angio-
graphy with ultra-low-volume contrast administration in 
the management of TRAS with impaired graft function in 
patients in whom stent implantation was necessary.
Material and methods
Thirty-three graft recipients with suspicion of TRAS 
based on clinical setting (persistent hypertension, ele-
vated serum creatinine, bruit over the graft) and elevated 
peak systolic velocity in TRA (> 200 cm/s) on Doppler-
ultrasound examination were considered for examina-
tion with IA-CTA. Fifteen patients were disqualified due 
to: significant graft dysfunction demanding dialysis, other 
causes of graft function deterioration (high level of calcineu-
rin inhibitors, rejection, infections), clinical symptoms im-
provement, or lack of consent for an invasive procedure [3]. 
Eighteen graft recipients were examined with IA-CTA. 
In 12 patients (67%) IA-CTA revealed difficult anatomi-
cal conditions (including significant or multiple kink-
ing) that made stenting impossible due to high risk of 
complications (for example complete occlusion of TRA). 
In six (33%) (three men and three women) graft recipients 
examined with IA-CTA severe stenosis eligible for stent 
implantation was revealed. The six graft recipients were 
treated with TRA stenting during the same procedure, 
preceded by thorough assessment of the TRAS in CT im-
age reconstructions performed by the operator. Informed 
consent was obtained in each case of IA-CTA and stent 
implantation. 
The IA-CTA was performed with an author-elaborat-
ed protocol using 8-18 ml of diluted 30% iodine contrast 
(iodixanol 320) administered at the speed of 4-5 ml/s 
through catheter placed about 2 cm below the aortic bi-
furcation. The catheter was inserted using either an ipsi-
lateral or contralateral inguinal arterial approach with the 
use of low-profile equipment (4F sheaths and catheters) in 
a cath lab located next door to the CT examination room. 
CTA examinations were performed with 64-slice Light-
Speed CT (GE Healthcare) and analysed using an AW 
4.4 (GE Healthcare) diagnostic station either manually or 
with Vessel Analysis software. In order to assess the length 
and severity of TRA narrowing 3D MIP (Maximum In-
tensity Projection) and CPR (Curved Planar Reconstruc-
tion) were made. After the analysis of stenosis, the stent 
implantation was performed. In four patients additional 
predilatation was done. In five patients correct patency of 
TRA was obtained, while in one TRA remained patent at 
ultra-low level. Serum creatinine level was measured at 
baseline and on each of the seven following days. EGFR 
was calculated using MDRD (modification of diet in renal 
disease) formula: GFR = 175 × standardised Scr − 1.154 
× age − 0.203 × 1.212 [if black] × 0.742 [if female], where 
GFR is expressed as ml/min/1.73 m2 of body surface area 
and Scr is expressed in mg/dl [4].
Results
The average age of the patients was equal to 54.3 ± 10.5 
years, CTA was performed 0.5 to 75.5 months after trans-
plantation, volume of the contrast given during ia-CTA 
was 8-18 ml, and mean serum creatinine concentration at 
baseline was 2.93 ± 0.89 mg/dl.
IA-CTA revealed critical stenosis in the trunk and the 
anastomosis in three patients, critical stenosis in the trunk 
in one, 70% stenosis of the trunk in one, critical stenosis 
in the anastomosis in one, and additional kinking of TRA 
in one case (Table 1). 
Stent administration resulted in good anatomical 
outcome. No complications of either arterial puncture or 
catheter insertion were observed. 
No long-term graft dysfunction was observed in the 
group. Mean serum creatinine measured three days after 
contrast administration was 2.89 ± 1.73 mg/dl. One patient 
presented a creatinine level elevation of 1.9 mg/dl, which 
decreased below the initial value within the four following 
days. In one patient elevation of 0.03 mg/dl was observed. 
In one case the creatinine remained at the same level. In 
three patients a decrease in serum creatinine level oc-
curred within three days from the procedure. In prolonged 
measurement mean creatinine level after seven days from 
CTA was lower and equalled 2.17 ± 0.51 mg/dl. The de-
crease of serum creatinine level between baseline and day 
7 was 0.2-1.64 mg/dl (mean 0.76 ± 0.54 mg/dl). Figure 1 
presents the serum creatinine level change trends on each 
of the seven following days after transplantation for all six 
patients. Mean eGFR (estimated glomerular filtration rate) 
was 6.3 ml/min/1.73 m2 higher than at the baseline. 
Discussion
Vascular complications of renal transplantation, includ-
ing TRAS, can result in graft loss. An effective screening 
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test and possibility of fast treatment introduction are es-
sential to maintain correct graft function. Several studies 
have been conducted in search of a sensitive and specific 
diagnostic measure for TRAS detection with as little inva-
sion as possible.
Etemadi et al. [5] proved that high levels of CaPO4 
product and LDL cholesterol are significantly correlated 
with the risk of TRAS one year after renal transplanta-
tion, which can be used in defining a risk group for TRAS 
among graft recipients. Doppler ultrasound imaging re-
mains a safe and accurate tool for TRAS diagnosis dur-
ing systematic follow-up after kidney transplantation [6]. 
All patients in our study presented abnormalities in Dop-
pler ultrasound examination of TRA after kidney trans-
plantation. Contrast-enhanced ultrasound [7] as well as 
magnetic resonance angiography (MRA) [8] are accurate 
and relatively safe methods for further and more detailed 
assessment of TRAS; however, these methods are less 
available than CTA. Bashir et al. presented an alternative, 
non-nephrotoxic MRA with the use of ferumoxytol as con-
trast agent [9], which could become an optimal diagnostic 
measure for TRAS in the future. Regular computed tomog-
raphy angiography enables detailed images of TRA abnor-
malities to be obtained. Nevertheless, it requires adminis-
tration of a high volume of iodine contrast, which carries 
a risk of graft failure in patients with already impaired graft 
function. Several studies proved that ultra-low-volume io-
dine contrast administered intra-arterially during CTA en-
sures optimal technical feasibility of this imaging method 
[10,11]. Moreover, intra-arterial puncture can be used for 
percutaneous intraluminal angioplasty and or without 
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Figure 1. The serum creatinine level alterations (A) and mean estimated 
glomerular filtration rate (eGFR) value (B) after stent implantation in over 
7-day observation 
Table 1. The data of patients, denoted as A-F, including their age, sex (M – male, F – female), time from transplantation, total volume of contrast administered, 
volume of contrast injected at IA-CTA, type of stenosis, and serum creatinine level (SCr) at baseline 
Age Sex Time after 
transplantation 
(months)
Volume of contrast 
in IA-CTA (ml)
Total volume of 
contrast (IA-CTA + stent 
implantation) (ml)
Type and severity 
of stenosis
SCr at the 
baseline 
(mg/dl)
A 63 M 5 8 100 Trunk + anastomosis; critical 3.5
B 61 F 7 8 100 Trunk + kinking; critical 2.5
C 64 M 75.5 15 15 Anastomosis; critical 1.9
D 54 F 0.5 18 168 Trunk + anastomosis; critical 4.4
E 46 M 3.5 8 80 Trunk; 70% 2.8
F 38 M 5.5 8 100 Trunk + anastomosis; critical 2.5
Figure 2. Intra-arterial computed tomography angiography with ultra-low 
volume of iodine contrast – a 3D reconstruction of the transplant renal ar-
tery with a detailed image of the stenosis 
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there is a short distance between the cath lab and CT room 
[10], as it was in the cases presented in this study.
According to “European Society of Urogenital Radiol-
ogy guidelines on contrast media” renal function should 
be measured within 48-72 hours after contrast applica-
tion [2]. In this study renal graft function parameters were 
controlled for a longer period (minimum seven days) to 
check both the effect of applied treatment as well as the 
reaction to iodine contrast administered during IA-CTA 
and stent implantation. In all cases a significant decrease 
in serum creatinine level at the end point was observed. 
In addition to minimising the amount of contrast, benefits 
from stent implantation outweighed the potential risk of 
graft failure due to contrast administration. Therefore, it is 
reasonable to use ultra-low-volume IA-CTA, particularly 
while applying treatment designed to improve the graft 
function. Effectiveness of TRA stenting in TRAS reaches 
80% [3] and enables graft function to be maintined for 
many years [12] if applied punctually.
This study had several limitations. No additional labo-
ratory factors connected with TRAS were measured. The 
group of patients examined was small, but it should be 
noted that TRAS requiring stent implantation is rare in 
the general population. We did not take into account any 
control group because the number of the patients under 
examination was small and the purpose of the study was 
to present the potential of the relatively new method of 
imaging of severe TRAS. The use of CT scanners with 
256 and more slices may potentially improve IA-CTA ex-
aminations in terms of volume of contrast medium and 
additional features (including graft perfusion). 
Conclusions
Intra-arterial CTA using an ultra-low volume of iodine 
contrast seems to be a safe diagnostic tool to asses TRAS 
in need of stent implantation. 
Application of IA-CTA with an ultra-low volume of 
iodine contrast may minimise the overall amount of con-
trast that patients receive in the management of TRAS. 
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